COMP insider plans sale of 197,568 common shares on NYSE

COMP filed a notice of proposed sale under Rule 144 covering 197,568 common shares, with an aggregate market value of $2,139,661.44.

Rhea-AI Filing Summary

COMP filed a notice of proposed sale under Rule 144 covering 197,568 common shares, with an aggregate market value of $2,139,661.44. The shares are planned to be sold on the NYSE around 01/07/2026 through Morgan Stanley Smith Barney LLC. The issuer had 561,061,452 common shares outstanding at the time referenced.

The shares to be sold include 142,882 shares acquired on 01/07/2026 via a cash exercise of stock options and 54,686 shares from restricted stock units dated 04/04/2023. In the past three months, sales under a 10b5-1 plan for Bradley Serwin included, for example, 20,953 shares sold on 11/25/2025 for $230,483.00 and 20,952 shares sold on 11/24/2025 for $219,996.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many COMP shares are covered by this Rule 144 notice?

The notice covers the proposed sale of 197,568 shares of COMP common stock with an aggregate market value of $2,139,661.44.

When are the COMP shares expected to be sold and on which exchange?

The approximate date of sale is 01/07/2026, and the shares are planned to be sold on the NYSE.

Which broker is handling the planned COMP share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004.

How were the COMP shares being sold under this Form 144 acquired?

Of the shares to be sold, 142,882 were acquired on 01/07/2026 through a cash exercise of stock options, and 54,686 were acquired as restricted stock units on 04/04/2023.

What recent 10b5-1 sales related to COMP are disclosed?

Recent 10b5-1 sales for Bradley Serwin include 20,953 shares sold on 11/25/2025 for $230,483.00 and 20,952 shares sold on 11/24/2025 for $219,996.00.

How many COMP shares were outstanding according to this filing?

The filing states that 561,061,452 common shares of the issuer were outstanding at the referenced time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001314040
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COMPASS INC
SEC File Number	001-40291
Address of Issuer	110 Fifth Avenue, 4th Floor New York NEW YORK 10011
Phone	6469820353
Name of Person for Whose Account the Securities are To Be Sold	BRADLEY SERWIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	197568	2139661.44	561061452	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2026	Exercise of Stock Options	Issuer			142882	01/07/2026	Cash
Common	04/04/2023	Restricted Stock Units	Issuer			54686	04/04/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/25/2025	20953	230483.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/24/2025	20952	219996.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/21/2025	13969	139690.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/12/2025	904	8588.00
10b5-1 Sales for BRADLEY SERWIN 110 Fifth Avenue, 4th Floor New York NY 10011	Common	11/11/2025	903	8127.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 4/4/2023 through 1/6/2025
Date of Notice	01/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bradley Serwin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)